News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,046 Results
Type
Article (40887)
Company Profile (258)
Press Release (657901)
Section
Business (205281)
Career Advice (2063)
Deals (35579)
Drug Delivery (94)
Drug Development (81135)
Employer Resources (171)
FDA (16199)
Job Trends (14976)
News (346730)
Policy (32693)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2619)
Accelerated approval (2)
Adcomms (20)
Allergies (77)
Alliances (49747)
ALS (76)
Alzheimer's disease (1329)
Antibody-drug conjugate (ADC) (98)
Approvals (16182)
Artificial intelligence (215)
Autoimmune disease (10)
Automation (14)
Bankruptcy (360)
Best Places to Work (11694)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (181)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (232)
Cancer (1793)
Cardiovascular disease (133)
Career advice (1722)
Career pathing (28)
CAR-T (130)
Cell therapy (374)
Cervical cancer (13)
Clinical research (65453)
Collaboration (703)
Compensation (393)
Complete response letters (18)
COVID-19 (2602)
CRISPR (31)
C-suite (180)
Cystic fibrosis (97)
Data (1714)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (223)
Diagnostics (6415)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (94)
Drug shortages (24)
Duchenne muscular dystrophy (64)
Earnings (85887)
Editorial (27)
Employer branding (22)
Employer resources (147)
Events (111755)
Executive appointments (592)
FDA (17166)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (632)
Gene editing (85)
Generative AI (20)
Gene therapy (257)
GLP-1 (666)
Government (4396)
Grass and pollen (4)
Guidances (46)
Healthcare (18890)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (92)
Indications (23)
Infectious disease (2722)
Inflammatory bowel disease (125)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (70)
Interviews (317)
IPO (16511)
IRA (40)
Job creations (3714)
Job search strategy (1470)
Kidney cancer (9)
Labor market (26)
Layoffs (447)
Leadership (16)
Legal (7937)
Liver cancer (68)
Lung cancer (260)
Lymphoma (119)
Machine learning (2)
Management (57)
Manufacturing (247)
MASH (57)
Medical device (13360)
Medtech (13365)
Mergers & acquisitions (19475)
Metabolic disorders (581)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (69)
Neuropsychiatric disorders (23)
Neuroscience (1758)
NextGen: Class of 2025 (6575)
Non-profit (4524)
Northern California (2215)
Now hiring (35)
Obesity (320)
Opinion (201)
Ovarian cancer (61)
Pain (69)
Pancreatic cancer (69)
Parkinson's disease (119)
Partnered (17)
Patents (180)
Patient recruitment (80)
Peanut (45)
People (57305)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20385)
Phase II (28836)
Phase III (21464)
Pipeline (807)
Podcasts (40)
Policy (101)
Postmarket research (2569)
Preclinical (8633)
Press Release (68)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (335)
Real estate (6040)
Recruiting (65)
Regulatory (22136)
Reports (43)
Research institute (2389)
Resumes & cover letters (353)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (115)
Series B (68)
Service/supplier (13)
Sickle cell disease (49)
Southern California (1896)
Special edition (13)
Sponsored (29)
Startups (3624)
State (2)
Stomach cancer (11)
Supply chain (57)
The Weekly (25)
United States (19503)
Vaccines (625)
Venture capitalists (34)
Webinars (12)
Weight loss (216)
Women's health (30)
Worklife (14)
Date
Today (168)
Last 7 days (758)
Last 30 days (2947)
Last 365 days (34483)
2025 (5712)
2024 (35367)
2023 (40252)
2022 (51416)
2021 (55934)
2020 (54410)
2019 (46899)
2018 (35247)
2017 (32447)
2016 (31873)
2015 (37854)
2014 (31619)
2013 (26711)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (739)
Alabama (48)
Alaska (7)
Arizona (214)
Arkansas (12)
Asia (37990)
Australia (6195)
California (5050)
Canada (1768)
China (416)
Colorado (231)
Connecticut (240)
Delaware (111)
Europe (81387)
Florida (743)
Georgia (178)
Idaho (58)
Illinois (466)
India (20)
Indiana (276)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (774)
Massachusetts (3846)
Michigan (201)
Minnesota (349)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1436)
New Mexico (28)
New York (1450)
North Carolina (873)
North Dakota (7)
Northern California (2215)
Ohio (183)
Oklahoma (13)
Oregon (32)
Pennsylvania (1145)
Puerto Rico (6)
Rhode Island (23)
South America (1117)
South Carolina (13)
South Dakota (1)
Southern California (1896)
Tennessee (83)
Texas (743)
Utah (156)
Virginia (118)
Washington D.C. (55)
Washington State (481)
West Virginia (3)
Wisconsin (44)
699,046 Results for "paladin labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Press Releases
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
November 15, 2024
·
4 min read
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.
June 12, 2023
·
2 min read
Press Releases
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
January 23, 2025
·
5 min read
Press Releases
Know Labs, Inc. Announces $300K Registered Direct Offering
December 13, 2024
·
4 min read
Business
Know Labs, Inc. Reports Second Quarter FY 2024 Results
Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024.
May 15, 2024
·
10 min read
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Press Releases
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024
·
1 min read
Business
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
Know Labs, Inc. today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year 2024 ended on March 31, 2024, on May 15, 2024, beginning at 1:30 pm PT.
May 8, 2024
·
3 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
1 of 69,905
Next
